Ronald Hafner

Ronald Hafner

Founder at NLS PHARMACEUTICS AG

Net worth: 449 561 $ as of 2024-06-29

60 year
Technology Services
Consumer Services
Commercial Services

Profile

Ronald Hafner is the founder of NLS Pharmaceutics Ltd., which was founded in 2015.
He is currently the Director at Covalo AG and the Partner at Deloitte Consulting GmbH.
In the past, he served as the Chief Executive Officer & Partner at Lodestone Management Consultants AG, the Chief Executive Officer at Infosys Consulting AG from 2012 to 2015, and as an Independent Director at Pingar Group Ltd.
from 2015 to 2016.
Mr. Hafner obtained an MBA from the University of Basel.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-13 2,071,710 ( 4.78% ) 449 561 $ 2024-06-29

Ronald Hafner active positions

CompaniesPositionStart
NLS PHARMACEUTICS AG Founder 2015-06-09
Deloitte Consulting GmbH Corporate Officer/Principal 2015-12-31
Director/Board Member -
All active positions of Ronald Hafner

Former positions of Ronald Hafner

CompaniesPositionEnd
Director/Board Member 2015-12-31
Infosys Consulting AG Chief Executive Officer 2015-02-28
Chief Executive Officer -
See the detail of Ronald Hafner's experience

Training of Ronald Hafner

University of Basel Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ronald Hafner's experience

Connections

23

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NLS PHARMACEUTICS AG

Health Technology

Private companies5

Commercial Services

Deloitte Consulting GmbH

Infosys Consulting AG

Technology Services

Technology Services

See company connections